2.18 0.03 (1.40%)

82.12% Fall from 52W High

109.0K XNAS Volume

XNAS 17 Apr, 2025 5:30 PM (EDT)

Board Meeting
The next board meeting for Zynex Inc is on 30 Apr 2025 for the purpose of Zynex Inc First Quarter Earnings Results for 2025 See details

Zynex Inc Key Metrics

Select
All financials are in USD Million and price data in USD
VIEW MORE
Medium Financial Strength
38.9 / 100
Affordable Valuation
65.8 / 100
Technically Bearish
23.2 / 100
Falling Comet These stocks are with medium quality with average financials but with good valuation score. However, their weak technical aspects reduces the investor interest. View Similar Embed DVM

Zynex Inc Live Price Chart

Switch to TradingView
Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

Created with Highcharts 7.2.2Dec '22Dec '23Dec '24Dec '25Dec '26150200100250Actual RevenueAvg. Estimate
Miss

Zynex Inc's Revenue was lower than average estimate 3 times in past 3 years

EPS forecast

Current EPS
0.1
Avg. Estimate
-0.5
Low Estimate
-0.6
High Estimate
-0.4
Current EPS
Avg. Estimate
Miss

EPS is expected to reduce by 644.4% in FY25

Consensus Recommendation

3 ANALYST Recommendations
HOLD

Created with Highcharts 7.2.22Hold1Buy

The consensus recommendation from 3 analysts for Zynex Inc is HOLD

Forecaster is a Premium Feature
You need to upgrade your subscription plan to access this feature
See what you get

Zynex Inc Stock Analysis

Zynex Inc stock analysis with key metrics, changes, and trends.

Zynex Inc MetricVALUECHANGE %TRENDANALYSIS
Annual Revenue$192.35 M4.36%positive

Annual Revenue rose 4.36%, in the last year to $192.35 M. Its sector's average revenue growth for the last fiscal year was 8.57%.

Annual Net Profit$2.99 M69.24%negative

Annual Net Profit fell 69.24% in the last year to $2.99 M. Its sector's average net profit growth for the last fiscal year was 4.36%.

Price to Earning Ratio22.01-positive

Price to Earning Ratio is 22.01, lower than its sector PE ratio of 29.09.

Stock Price$2.18-80.84%negative

Stock Price fell 80.84% and underperformed its sector by 86.27% in the past year.

Quarterly Revenue$45.97 M2.77%negative

Quarterly Revenue fell 2.77% YoY to $45.97 M. Its sector's average revenue growth YoY for the quarter was 8.5%.

Quarterly Net profit$0.62 M150.62%negative

Quarterly Net profit fell 150.62% YoY to $0.62 M. Its sector's average net profit growth YoY for the quarter was 32.89%.

Debt to Equity Ratio2.07-negative

Debt to Equity Ratio of 2.07 is higher than 1. This implies that company assets are financed through debt.

Return on Equity(ROE)7.32 %7.32%negative

Return on Equity(ROE) for the last financial year was 7.32%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

Mutual Fund Holding19.25 %-0.31%negative

Mutual Fund Holding decreased by 0.31% in the last quarter to 19.25.

Promoter Share Holding39.69 %-5.27%negative

Promoter Share Holding decreased by 5.27% in the most recent quarter to 39.69%.

Interest Coverage Ratio2.52-positive

Interest Coverage Ratio is 2.52, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).

Institutional Holding25.53 %-1.32%negative

Institutional Holding decreased by 1.32% in the last quarter to 25.53.

VIEW LESS


Loading data..

Zynex Inc - Company Profile

What does Zynex Inc do?

Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.

Zynex Inc Management structure

All Gross Remunerations are in USD
Mr. Thomas Sandgaard
Chairman of the Board, President and Chief Executive Officer
991.81 K
2024
Gross Remuneration
Year
Mr. Daniel J. Moorhead
Chief Financial Officer
909.81 K
2024
Gross Remuneration
Year
Ms. Anna Lucsok
Chief Operating Officer
709.11 K
2024
Gross Remuneration
Year

Zynex Inc Board of directors

All Gross Remunerations are in USD
Mr. Barry D. Michaels
Independent Director
175 K
2024
Gross Remuneration
Year
Mr. Joshua R. Disbrow
Independent Director
170 K
2024
Gross Remuneration
Year
Mr. Michael Cress
Independent Director
170 K
2024
Gross Remuneration
Year
Mr. Thomas Sandgaard
Chairman of the Board, President and Chief Executi
-
2024
Gross Remuneration
Year

Zynex Inc FAQ

How is Zynex Inc today?
Zynex Inc today is trading in the green, and is up by 1.40% at 2.18.
Zynex Inc is currently trading up 1.40% on an intraday basis. In the past week the stock fell 0.00%. stock has been down -71.61% in the past quarter and fell -80.84% in the past year. You can view this in the overview section.